Results summary | View all lists in L2L MDB | View all genes in C05AA.profile.ud50 |
Down-regulated at any timepoint following treatment of WS1 human skin fibroblasts with UVC at a high dose (50 J/m^2) (clusters d1-d9) enrichment: 2.87-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
201041_S_AT | DUSP1 | X | E | P | dual specificity phosphatase 1 | ||||||||
208581_X_AT | MT1X | metallothionein 1X | |||||||||||
205409_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
208937_S_AT | ID1 | D | R | S | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||||
209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 |